Zydus Lifesciences Ltd receives EIR from the USFDA for its injectable facility with VAI classification

Zydus Lifesciences Limited has received the Establishment Inspection Report (EIR) from the USFDA for its injectable facility located at Zydus Biotech Park, Ahmedabad, with Voluntary Action Indicated (VAI) classification. The GMP surveillance inspection was conducted from 27th April to 5th May 2026.

Shares of Zydus Lifesciences Limited was last trading in BSE at Rs. 1126.50 as compared to the previous close of Rs. 1115.50. The total number of shares traded during the day was 157237 in over 6131 trades.

The stock hit an intraday high of Rs. 1134.25 and intraday low of 1101.30. The net turnover during the day was Rs. 176318554.00.

Source : Equity Bulls

Keywords

ZydusLifesciences INE010B01027 Pharmaceuticals USFDA EIR InjectableFacility VAIClassification